4 Analysts Have This To Say About Health Catalyst

Across the recent three months, 4 analysts have shared their insights on Health Catalyst (NASDAQ: HCAT ), expressing a ...
Nasdaq

Clover Health Investments Reaches Analyst Target Price

In recent trading, shares of Clover Health Investments Corp (Symbol: CLOV) have crossed above the average analyst 12-month target price of $3.77, changing hands for $3.82/share. When a stock reaches ...
TipRanks on MSN

Evolent Health price target lowered to $10 from $11 at Citizens

Citizens analyst Constantine Davides lowered the firm’s price target on Evolent Health (EVH) to $10 from $11 and keeps an Outperform rating on the ...
TipRanks on MSN

Guardant Health price target raised to $115 from $85 at Guggenheim

Guggenheim analyst Subbu Nambi raised the firm’s price target on Guardant Health (GH) to $115 from $85 and keeps a Buy rating on the shares. The ...